SCHEMBL32671998

SCHEMBL32671998

Cc1ccccc1-c1cnc(NC(=O)Oc2ccccc2)s1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNE1 P24864 1/20 0.64
CDK2 P24941 1/20 0.64
CDK5 Q00535 1/20 0.64
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
ALDH1A1 P00352 3/20 0.49
POLB P06746 1/20 0.49
MIF P14174 1/20 0.49
NAMPT P43490 1/20 0.47
TP53 P04637 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
LIMK1 P53667 2/20 0.46
CSNK2A2 P19784 3/20 0.45
CSNK2A1 P68400 3/20 0.45
KDR P35968 1/20 0.45
LMNA P02545 2/20 0.44
GAA P10253 1/20 0.44
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13453223 0.83 CCNE1 (0.67) CCNE1CDK2CDK5KMT2AMEN1
SCHEMBL895339 0.81 CCNE1 (0.69) CCNE1CDK2CDK5KMT2AMEN1
SCHEMBL16526111 0.80 LIMK1 (0.72) CCNE1CDK2CDK5LIMK1
SCHEMBL24232850 0.79 CSNK2A2 (0.64) CCNE1CDK2CDK5KMT2AMEN1
SCHEMBL1895794 0.79 CCNE1 (0.65) CCNE1CDK2CDK5KMT2AMEN1
SCHEMBL32672015 0.79 CCNE1 (0.62) CCNE1CDK2CDK5KMT2AMEN1
SCHEMBL24232863 0.79 CCNE1 (0.62) CCNE1CDK2CDK5KMT2AMEN1
SCHEMBL19974175 0.78 ALDH1A1 (0.51) CCNE1CDK2CDK5KMT2AMEN1
SCHEMBL19974176 0.78 ALDH1A1 (0.51) CCNE1CDK2CDK5KMT2AMEN1
SCHEMBL32671861 0.76 CCNE1 (0.65) CCNE1CDK2CDK5KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630562-B2 Piperidylurea compounds and methods of use thereof ARCUS BIOSCIENCES, INC. (US) 2026-05-19 US disclosed
US-20260042777-A1 PIPERIDYLUREA COMPOUNDS AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. (US) 2026-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630562-B2 Piperidylurea compounds and methods of use thereof CLIC1, HCCS, CNR1 CCNE1 768/4885CDK2 941/4885CDK5 2440/4885
US-20260042777-A1 PIPERIDYLUREA COMPOUNDS AND METHODS OF USE THEREOF CBR1, CLIC1, RER1 CCNE1 684/4885CDK2 747/4885CDK5 2122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.